Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)
China · Delayed Price · Currency is CNY 5.91
-0.01 (-0.17%)
Jun 11, 2026, 3:04 PM CST
SHE:002107 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 109.5 | 95.72 | 36.4 | 58.77 | 107.39 | 163.39 |
Depreciation & Amortization | 31.51 | 31.51 | 32.47 | 33.22 | 35.33 | 33.05 |
Loss (Gain) From Sale of Assets | - | - | - | -0.07 | -2.15 | - |
Asset Writedown & Restructuring Costs | 0.17 | 0.17 | 0.03 | 0.06 | 0.44 | 13.56 |
Loss (Gain) From Sale of Investments | -1.76 | -1.76 | - | - | - | - |
Provision & Write-off of Bad Debts | 0.34 | 0.34 | -1.02 | -1.96 | 1.72 | -0.91 |
Other Operating Activities | -2.67 | -8.36 | 1.56 | -9.07 | -12.36 | 5.07 |
Change in Accounts Receivable | 3.3 | 3.3 | 28.14 | 50.32 | -40.84 | 63.28 |
Change in Inventory | 11.72 | 11.72 | 40.65 | -5.36 | 15.49 | -53.83 |
Change in Accounts Payable | -4.31 | -4.31 | -46 | 2.63 | 78.07 | -24.82 |
Operating Cash Flow | 148 | 128.53 | 91.51 | 129.25 | 185.26 | 200.12 |
Operating Cash Flow Growth | 73.73% | 40.45% | -29.20% | -30.23% | -7.43% | 1.80% |
Capital Expenditures | -1.52 | -0.86 | -3.82 | -2.72 | -6.77 | -19.08 |
Sale of Property, Plant & Equipment | 0 | 14.65 | 0.03 | 0.09 | 1.16 | - |
Divestitures | 0.82 | 0.82 | - | - | - | - |
Other Investing Activities | - | - | 0.19 | - | - | - |
Investing Cash Flow | -0.7 | 14.61 | -3.6 | -2.62 | -5.6 | -19.08 |
Long-Term Debt Issued | - | - | - | - | 0.28 | - |
Total Debt Issued | - | - | - | - | 0.28 | - |
Long-Term Debt Repaid | - | -1.14 | -0.35 | -0.61 | -0.24 | -188.84 |
Total Debt Repaid | -1.14 | -1.14 | -0.35 | -0.61 | -0.24 | -188.84 |
Net Debt Issued (Repaid) | -1.14 | -1.14 | -0.35 | -0.61 | 0.04 | -188.84 |
Common Dividends Paid | -153.54 | -69.27 | -144.3 | - | -150.07 | -154.86 |
Other Financing Activities | -21.28 | -21.57 | - | -2.94 | -79.28 | - |
Financing Cash Flow | -175.95 | -91.97 | -144.65 | -3.55 | -229.32 | -343.69 |
Net Cash Flow | -28.65 | 51.16 | -56.74 | 123.07 | -49.67 | -162.65 |
Free Cash Flow | 146.48 | 127.66 | 87.69 | 126.53 | 178.49 | 181.04 |
Free Cash Flow Growth | 79.89% | 45.59% | -30.70% | -29.11% | -1.41% | 27.13% |
Free Cash Flow Margin | 17.90% | 15.63% | 11.48% | 13.91% | 17.59% | 19.20% |
Free Cash Flow Per Share | 0.26 | 0.23 | 0.14 | 0.21 | 0.32 | 0.31 |
Cash Interest Paid | - | - | - | 0.24 | 0.34 | 1.16 |
Cash Income Tax Paid | 113.94 | 111.89 | 99.58 | 134.26 | 138.53 | 140.6 |
Levered Free Cash Flow | 109.29 | 111.02 | 79.04 | 114.06 | 143.68 | 105.97 |
Unlevered Free Cash Flow | 109.32 | 111.06 | 79.05 | 114.08 | 143.69 | 108.9 |
Change in Working Capital | 10.92 | 10.92 | 22.07 | 48.29 | 54.9 | -14.04 |